Published in J Viral Hepat on May 01, 1999
HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? J Viral Hepat (2008) 1.45
Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes. J Virol (2009) 1.41
Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients. Sci Transl Med (2014) 1.39
Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology (2005) 1.26
High prevalence and genetic diversity of HCV among HIV-1 infected people from various high-risk groups in China. PLoS One (2010) 1.15
Acute hepatitis C virus infection: a chronic problem. Hepatology (2008) 1.15
Hepatitis C and HIV-1 coinfection. Gut (2002) 1.12
Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection. PLoS One (2013) 1.00
Quantification of hepatitis C virus (HCV) in liver specimens and sera from patients with human immunodeficiency virus coinfection by using the Versant HCV RNA 3.0 (branched DNA-based) DNA assay. J Clin Microbiol (2003) 0.92
Opioids and HIV/HCV infection. J Neuroimmune Pharmacol (2011) 0.91
Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection. J Viral Hepat (2013) 0.85
Detection and characterization of hepatitis C virus RNA in seminal plasma and spermatozoon fractions of semen from patients attempting medically assisted conception. J Clin Microbiol (2002) 0.85
Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report. Oncologist (2010) 0.81
Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China. Hepat Mon (2012) 0.80
Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial. Dig Dis Sci (2005) 0.80
Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China. PLoS One (2014) 0.76
Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR. Virology (2015) 0.76
Analytical and biological variables influencing quantitative hepatitis C virus (HCV) measurement in HIV-HCV coinfection. Can J Gastroenterol (2006) 0.75
Characteristics of hepatitis C virus infection in HIV-infected people. Can J Infect Dis (2001) 0.75
HCV viremia associates with NK cell activation and dysfunction in anti retroviral HIV/HCV co-infected subjects. J Viral Hepat (2017) 0.75
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73
Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Cloning and characterization of a Pseudomonas mendocina KR1 gene cluster encoding toluene-4-monooxygenase. J Bacteriol (1991) 3.01
A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta. J Virol (1988) 2.99
Conversion of logarithmic channel numbers into relative linear fluorescence intensity. Cytometry (1988) 2.96
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A (2000) 2.70
Long-term therapy of chronic hepatitis B with lamivudine. Hepatology (2000) 2.49
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Long-term therapy of chronic delta hepatitis with peginterferon alfa. Aliment Pharmacol Ther (2014) 2.19
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis (1995) 2.07
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06
Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol (2000) 2.06
Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol (2001) 2.06
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med (2008) 2.03
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J (2001) 2.03
Third consensus on medical treatment of metastatic breast cancer. Ann Oncol (2009) 1.96
Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology (1998) 1.84
Muscular equivalent of the lower esophageal sphincter. Gastroenterology (1979) 1.83
[Driving tests to determine the influence of alcohol, tranquilizers and hypnotics on driing capability]. Dtsch Med Wochenschr (1969) 1.81
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites. Lancet (2009) 1.81
Epidemiology of hepatocellular carcinoma. Can J Gastroenterol (2000) 1.80
Predictors of duodenal ulcer healing and relapse. Gastroenterology (1981) 1.78
Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab (1987) 1.78
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
[Traffic, tranquilizing agents and alcohol]. Dtsch Med Wochenschr (1967) 1.77
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med (2012) 1.76
Fulminant B viral hepatitis: role of delta agent. Gastroenterology (1984) 1.74
Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology (1983) 1.70
Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol (1995) 1.66
The use of toxic equivalency factors in assessing occupational and environmental health risk associated with exposure to airborne mixtures of polycyclic aromatic hydrocarbons (PAHs). Chemosphere (1996) 1.63
The adaptive evolution database (TAED). Genome Biol (2001) 1.62
NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J Immunol (2000) 1.60
Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med (1996) 1.56
Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc Natl Acad Sci U S A (2001) 1.54
Variation in course of hepatitis E in experimentally infected cynomolgus monkeys. J Infect Dis (1993) 1.52
Longitudinal threshold changes in older men with audiometric notches. Hear Res (2000) 1.51
Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst (1991) 1.50
Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest (2003) 1.49
Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology (2000) 1.49
Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat (2000) 1.45
Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: preliminary study. Arch Neurol (1997) 1.45
10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology (1998) 1.44
Lamivudine for chronic delta hepatitis. Hepatology (1999) 1.44
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer (2012) 1.41
[Obstruction ileus caused by mushrooms]. Schweiz Med Wochenschr (1989) 1.39
Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol (1997) 1.39
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis. Clin Infect Dis (2016) 1.39
Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool. J Infect Dis (1998) 1.38
Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci U S A (1994) 1.38
Primary hepatocellular carcinoma following perinatal transmission of hepatitis B. West J Med (1988) 1.38
Hepatitis C antibodies in patients with alcoholic liver disease commonly have an identifiable risk factor. J Clin Gastroenterol (1992) 1.38
Second consensus on medical treatment of metastatic breast cancer. Ann Oncol (2006) 1.37
Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol (2001) 1.37
Experimental transmission of hepatitis C virus-associated fulminant hepatitis to a chimpanzee. J Infect Dis (1999) 1.35
Melanoma-associated antigens as messenger RNA detection markers for melanoma. Cancer Res (1997) 1.35
cDNA clone of hepatitis A virus encoding a virulent virus: induction of viral hepatitis by direct nucleic acid transfection of marmosets. J Virol (1992) 1.33
Twenty years of the German Environmental Survey (GerES): human biomonitoring--temporal and spatial (West Germany/East Germany) differences in population exposure. Int J Hyg Environ Health (2007) 1.30
Complementary and alternative medicine in chronic liver disease. Hepatology (2001) 1.29
mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology (2001) 1.28
Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology (1997) 1.28
Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer. Eur J Cancer (1996) 1.26
A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China. Int J Cancer (1995) 1.26
Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc Natl Acad Sci U S A (1996) 1.25
Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. Hepatology (1997) 1.25
Heterogeneity of hepatitis delta antigen. Virology (1990) 1.23
Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med (1996) 1.23
German health-related environmental monitoring: assessing time trends of the general population's exposure to heavy metals. Int J Hyg Environ Health (2013) 1.23
Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection. J Viral Hepat (1996) 1.21
Piperazinediium dioxamate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.21
Covalent binding of formalin fixed paraffin embedded brain tissue sections to glass slides suitable for in situ hybridization. J Virol Methods (1987) 1.21
Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology (1992) 1.18
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis (2000) 1.18
Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology (1997) 1.17
Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology (1991) 1.17
Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. HIV Med (2008) 1.16
Pharmacokinetics of pentachlorophenol in man. Arch Toxicol (1986) 1.15
Advances in directed protein evolution by recursive genetic recombination: applications to therapeutic proteins. Curr Opin Biotechnol (2001) 1.14
A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group. Dig Dis Sci (1991) 1.13
Distal 2q duplication: report of two familial cases and an attempt to define a syndrome. Am J Med Genet (1979) 1.13
Evolution of hepatitis delta virus RNA during chronic infection. Virology (1992) 1.13
Functional inferences from reconstructed evolutionary biology involving rectified databases--an evolutionarily grounded approach to functional genomics. Res Microbiol (2000) 1.13
Variable and multiple expression of Protease Nexin-1 during mouse organogenesis and nervous system development. Development (1993) 1.10
Smoking as an independent risk factor for hepatocellular carcinoma: the Singapore Chinese Health Study. Br J Cancer (2011) 1.10
Heart rate performance curve during incremental cycle ergometer exercise in healthy young male subjects. Med Sci Sports Exerc (1997) 1.09
Regulation of hepatic glycogen synthetase. Stimulation of glycogen synthetase in an in vitro liver system by insulin bound to sepharose. J Biol Chem (1971) 1.09
Orbital metastases in breast cancer: report of two cases and review of the literature. J Cancer Res Clin Oncol (2004) 1.09
Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology (1994) 1.09
A comparative analysis of N-myc and c-myc expression and cellular proliferation in mouse organogenesis. Mech Dev (1991) 1.08
Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver. J Immunol (2001) 1.07
Hydatid cyst of the cardiac interventricular septum: report of two cases. Br J Radiol (2007) 1.06